Zealand Pharma major shareholder announcement: Van Herk Investments

2 years ago

Company announcement – No. 6 / 2024 Zealand Pharma major shareholder announcement: Van Herk Investments Copenhagen, Denmark, 26 January 2024 – Zealand…

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering

2 years ago

HANOVER, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical…

Patient Safety Movement Foundation’s Mid-Year Meeting Charts Course for Global Patient Safety Initiatives in 2024

2 years ago

IRVINE, Calif.--(BUSINESS WIRE)--The Patient Safety Movement Foundation (PSMF) convened its annual Mid-Year Event to discuss safety challenges in the healthcare…

ObjectiveHealth Announces Strategic Growth Investment from Vitruvian Partners

2 years ago

NASHVILLE, Tenn.--(BUSINESS WIRE)--#centersofexcellence--ObjectiveHealth, a leading integrated specialty research network and technology company, announced today that it has secured a strategic…

Delota Corp. Announces Intention to Complete Debt Settlements

2 years ago

Vaughan, Ontario--(Newsfile Corp. - January 26, 2024) - Delota Corp. (CSE: LOTA) ("Delota" or the "Company") is pleased to announce…

Advancing Imaging Without Barriers! at ECR 2024, AGFA HealthCare Shows How Enterprise Imaging Enables ‘Next-Generation Radiology’

2 years ago

At ECR in Vienna, AGFA HealthCare will demonstrate how it delivers on promises of ‘next-generation radiology' with innovations to enable…

Unexpected Inspiration for More Sustainable Drug Development at Merck

2 years ago

NORTHAMPTON, MA / ACCESSWIRE / January 26, 2024 / Inspiration for a greener world can come from unexpected places. For…

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

2 years ago

NEW YORK--(BUSINESS WIRE)--Deliberate AI, a digital health technology company that delivers precision measurement of mental health through AI, today announced…

Optimind Pharma – Debenture Conversion

2 years ago

TORONTO, ON / ACCESSWIRE / January 26, 2024 / Optimind Pharma Corp. (CSE:OMND) (the "Optimind" or the "Company") advises that…

Planet 13 to Restate Certain Previously Issued Financial Statements

2 years ago

LAS VEGAS, NV / ACCESSWIRE / January 26, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company"),…